Avalo Therapeutics, Inc. · NASDAQ:AVTX

Caligan Partners LP reported a 6.30% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

Caligan Partners LP reported a 6.30% stake in Avalo Therapeutics, Inc., 833,333 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
6.30%
Shares
833,333
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP6.30%833,333
David Johnson6.30%833,333

Source

View original at SEC

Related